Phase 1 trials of the Neo-Kidney Augment, a novel, personalized treatment designed to enhance or replace kidney function in patients nearing renal failure, are under way in Sweden and the United States. Developed by regenerative medicine company Tengion, the Neo-Kidney Augment uses tubular epithelial cells taken from a biopsy of a patient’s diseased kidney. Over … Continue reading Neo-Kidney Augment Phase 1 Trials Under Way
Skip to content
UKRO – University Kidney Research Organization
Together We Build a Kidney